Skip to content
healthcare.dev

Irinotecan Hydrochloride

NDC 63323-193, IRINOTECAN HYDROCHLORIDE, injection, solution, from Fresenius Kabi USA, LLC.

Product NDC
63323-193
Status
Listed
Labeler
Fresenius Kabi USA, LLC
Dosage form
INJECTION, SOLUTION
Route
INTRAVENOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA077776
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/63323-193 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • IRINOTECAN HYDROCHLORIDE20 mg/mL

Pharmacologic classes

Topoisomerase Inhibitor [EPC]; Topoisomerase Inhibitors [MoA]

Package NDCNDC-11Package
63323-193-52633230193521 VIAL in 1 BOX (63323-193-52) / 2 mL in 1 VIAL
63323-193-55633230193551 VIAL in 1 BOX (63323-193-55) / 5 mL in 1 VIAL

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/ee45f127-8450-4455-a945-a1f5707f1d39
  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=63323-193

Use it

Look up 63323-193 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/63323-193 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 63323-193. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.